img

Global Decoagulant Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Decoagulant Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Decoagulant report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Decoagulant market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from VTE and ACS/MI are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Decoagulant industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Decoagulant key manufacturers include Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), AstraZeneca, Bristol-Myers Squibb, Aspen and Lilly, etc. Sanofi, Bayer, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Decoagulant can be divided into Platelet Aggregation Inhibitors (PAI), Low-Molecular-Weight Heparin (LMWH), Direct Thrombin Inhibitor (DTI) and Direct Factor Xa Inhibitors (DFXa), etc. Platelet Aggregation Inhibitors (PAI) is the mainstream product in the market, accounting for % sales share globally in 2022.
Decoagulant is widely used in various fields, such as VTE, ACS/MI, AF and Others, etc. VTE provides greatest supports to the Decoagulant industry development. In 2022, global % sales of Decoagulant went into VTE filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Decoagulant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Bayer
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
Segment by Type
Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K Antagonists (VKA)
Others

Segment by Application


VTE
ACS/MI
AF
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Decoagulant market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Decoagulant, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Decoagulant industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Decoagulant in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Decoagulant introduction, etc. Decoagulant Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Decoagulant market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Decoagulant Market Overview
1.1 Decoagulant Product Overview
1.2 Decoagulant Market Segment by Type
1.2.1 Platelet Aggregation Inhibitors (PAI)
1.2.2 Low-Molecular-Weight Heparin (LMWH)
1.2.3 Direct Thrombin Inhibitor (DTI)
1.2.4 Direct Factor Xa Inhibitors (DFXa)
1.2.5 Vitamin K Antagonists (VKA)
1.2.6 Others
1.3 Global Decoagulant Market Size by Type
1.3.1 Global Decoagulant Market Size Overview by Type (2018-2034)
1.3.2 Global Decoagulant Historic Market Size Review by Type (2018-2024)
1.3.3 Global Decoagulant Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Decoagulant Sales Breakdown by Type (2018-2024)
1.4.2 Europe Decoagulant Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Decoagulant Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Decoagulant Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Decoagulant Sales Breakdown by Type (2018-2024)
2 Global Decoagulant Market Competition by Company
2.1 Global Top Players by Decoagulant Sales (2018-2024)
2.2 Global Top Players by Decoagulant Revenue (2018-2024)
2.3 Global Top Players by Decoagulant Price (2018-2024)
2.4 Global Top Manufacturers Decoagulant Manufacturing Base Distribution, Sales Area, Product Type
2.5 Decoagulant Market Competitive Situation and Trends
2.5.1 Decoagulant Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Decoagulant Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decoagulant as of 2022)
2.7 Date of Key Manufacturers Enter into Decoagulant Market
2.8 Key Manufacturers Decoagulant Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Decoagulant Status and Outlook by Region
3.1 Global Decoagulant Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Decoagulant Historic Market Size by Region
3.2.1 Global Decoagulant Sales in Volume by Region (2018-2024)
3.2.2 Global Decoagulant Sales in Value by Region (2018-2024)
3.2.3 Global Decoagulant Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Decoagulant Forecasted Market Size by Region
3.3.1 Global Decoagulant Sales in Volume by Region (2024-2034)
3.3.2 Global Decoagulant Sales in Value by Region (2024-2034)
3.3.3 Global Decoagulant Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Decoagulant by Application
4.1 Decoagulant Market Segment by Application
4.1.1 VTE
4.1.2 ACS/MI
4.1.3 AF
4.1.4 Others
4.2 Global Decoagulant Market Size by Application
4.2.1 Global Decoagulant Market Size Overview by Application (2018-2034)
4.2.2 Global Decoagulant Historic Market Size Review by Application (2018-2024)
4.2.3 Global Decoagulant Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Decoagulant Sales Breakdown by Application (2018-2024)
4.3.2 Europe Decoagulant Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Decoagulant Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Decoagulant Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Decoagulant Sales Breakdown by Application (2018-2024)
5 North America Decoagulant by Country
5.1 North America Decoagulant Historic Market Size by Country
5.1.1 North America Decoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Decoagulant Sales in Volume by Country (2018-2024)
5.1.3 North America Decoagulant Sales in Value by Country (2018-2024)
5.2 North America Decoagulant Forecasted Market Size by Country
5.2.1 North America Decoagulant Sales in Volume by Country (2024-2034)
5.2.2 North America Decoagulant Sales in Value by Country (2024-2034)
6 Europe Decoagulant by Country
6.1 Europe Decoagulant Historic Market Size by Country
6.1.1 Europe Decoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Decoagulant Sales in Volume by Country (2018-2024)
6.1.3 Europe Decoagulant Sales in Value by Country (2018-2024)
6.2 Europe Decoagulant Forecasted Market Size by Country
6.2.1 Europe Decoagulant Sales in Volume by Country (2024-2034)
6.2.2 Europe Decoagulant Sales in Value by Country (2024-2034)
7 Asia-Pacific Decoagulant by Region
7.1 Asia-Pacific Decoagulant Historic Market Size by Region
7.1.1 Asia-Pacific Decoagulant Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Decoagulant Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Decoagulant Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Decoagulant Forecasted Market Size by Region
7.2.1 Asia-Pacific Decoagulant Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Decoagulant Sales in Value by Region (2024-2034)
8 Latin America Decoagulant by Country
8.1 Latin America Decoagulant Historic Market Size by Country
8.1.1 Latin America Decoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Decoagulant Sales in Volume by Country (2018-2024)
8.1.3 Latin America Decoagulant Sales in Value by Country (2018-2024)
8.2 Latin America Decoagulant Forecasted Market Size by Country
8.2.1 Latin America Decoagulant Sales in Volume by Country (2024-2034)
8.2.2 Latin America Decoagulant Sales in Value by Country (2024-2034)
9 Middle East and Africa Decoagulant by Country
9.1 Middle East and Africa Decoagulant Historic Market Size by Country
9.1.1 Middle East and Africa Decoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Decoagulant Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Decoagulant Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Decoagulant Forecasted Market Size by Country
9.2.1 Middle East and Africa Decoagulant Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Decoagulant Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Decoagulant Products Offered
10.1.5 Sanofi Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Decoagulant Products Offered
10.2.5 Bayer Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Decoagulant Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson Decoagulant Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Genentech (Roche)
10.5.1 Genentech (Roche) Company Information
10.5.2 Genentech (Roche) Introduction and Business Overview
10.5.3 Genentech (Roche) Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Genentech (Roche) Decoagulant Products Offered
10.5.5 Genentech (Roche) Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AstraZeneca Decoagulant Products Offered
10.6.5 AstraZeneca Recent Development
10.7 Bristol-Myers Squibb
10.7.1 Bristol-Myers Squibb Company Information
10.7.2 Bristol-Myers Squibb Introduction and Business Overview
10.7.3 Bristol-Myers Squibb Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bristol-Myers Squibb Decoagulant Products Offered
10.7.5 Bristol-Myers Squibb Recent Development
10.8 Aspen
10.8.1 Aspen Company Information
10.8.2 Aspen Introduction and Business Overview
10.8.3 Aspen Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Aspen Decoagulant Products Offered
10.8.5 Aspen Recent Development
10.9 Lilly
10.9.1 Lilly Company Information
10.9.2 Lilly Introduction and Business Overview
10.9.3 Lilly Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Lilly Decoagulant Products Offered
10.9.5 Lilly Recent Development
10.10 Otsuka
10.10.1 Otsuka Company Information
10.10.2 Otsuka Introduction and Business Overview
10.10.3 Otsuka Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Otsuka Decoagulant Products Offered
10.10.5 Otsuka Recent Development
10.11 Pfizer
10.11.1 Pfizer Company Information
10.11.2 Pfizer Introduction and Business Overview
10.11.3 Pfizer Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Pfizer Decoagulant Products Offered
10.11.5 Pfizer Recent Development
10.12 Daiichi Sankyo
10.12.1 Daiichi Sankyo Company Information
10.12.2 Daiichi Sankyo Introduction and Business Overview
10.12.3 Daiichi Sankyo Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Daiichi Sankyo Decoagulant Products Offered
10.12.5 Daiichi Sankyo Recent Development
10.13 The Medicines Company
10.13.1 The Medicines Company Company Information
10.13.2 The Medicines Company Introduction and Business Overview
10.13.3 The Medicines Company Decoagulant Sales, Revenue and Gross Margin (2018-2024)
10.13.4 The Medicines Company Decoagulant Products Offered
10.13.5 The Medicines Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Decoagulant Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Decoagulant Industrial Chain Analysis
11.4 Decoagulant Market Dynamics
11.4.1 Decoagulant Industry Trends
11.4.2 Decoagulant Market Drivers
11.4.3 Decoagulant Market Challenges
11.4.4 Decoagulant Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Decoagulant Distributors
12.3 Decoagulant Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Platelet Aggregation Inhibitors (PAI)
Table 2. Major Company of Low-Molecular-Weight Heparin (LMWH)
Table 3. Major Company of Direct Thrombin Inhibitor (DTI)
Table 4. Major Company of Direct Factor Xa Inhibitors (DFXa)
Table 5. Major Company of Vitamin K Antagonists (VKA)
Table 6. Major Company of Others
Table 7. Global Decoagulant Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Decoagulant Sales by Type (2018-2024) & (K Doses)
Table 9. Global Decoagulant Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Decoagulant Sales by Type (2018-2024) & (US& Million)
Table 11. Global Decoagulant Market Share in Value by Type (2018-2024)
Table 12. Global Decoagulant Price by Type (2018-2024) & (USD/Dose)
Table 13. Global Decoagulant Sales by Type (2024-2034) & (K Doses)
Table 14. Global Decoagulant Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Decoagulant Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Decoagulant Sales Market Share in Value by Type (2024-2034)
Table 17. Global Decoagulant Price by Type (2024-2034) & (USD/Dose)
Table 18. North America Decoagulant Sales by Type (2018-2024) & (K Doses)
Table 19. North America Decoagulant Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Decoagulant Sales (K Doses) by Type (2018-2024)
Table 21. Europe Decoagulant Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Decoagulant Sales (K Doses) by Type (2018-2024)
Table 23. Asia-Pacific Decoagulant Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Decoagulant Sales (K Doses) by Type (2018-2024)
Table 25. Latin America Decoagulant Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Decoagulant Sales (K Doses) by Type (2018-2024)
Table 27. Middle East and Africa Decoagulant Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Decoagulant Sales by Company (2018-2024) & (K Doses)
Table 29. Global Decoagulant Sales Share by Company (2018-2024)
Table 30. Global Decoagulant Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Decoagulant Revenue Share by Company (2018-2024)
Table 32. Global Market Decoagulant Price by Company (2018-2024) & (USD/Dose)
Table 33. Global Decoagulant Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Decoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decoagulant as of 2022)
Table 36. Date of Key Manufacturers Enter into Decoagulant Market
Table 37. Key Manufacturers Decoagulant Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Decoagulant Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Decoagulant Sales by Region (2018-2024) & (K Doses)
Table 41. Global Decoagulant Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Decoagulant Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Decoagulant Sales Market Share in Value by Region (2018-2024)
Table 44. Global Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 45. Global Decoagulant Sales by Region (2024-2034) & (K Doses)
Table 46. Global Decoagulant Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Decoagulant Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Decoagulant Sales Market Share in Value by Region (2024-2034)
Table 49. Global Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 50. Global Decoagulant Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Decoagulant Sales by Application (2018-2024) & (K Doses)
Table 52. Global Decoagulant Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Decoagulant Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Decoagulant Sales Market Share in Value by Application (2018-2024)
Table 55. Global Decoagulant Price by Application (2018-2024) & (USD/Dose)
Table 56. Global Decoagulant Sales by Application (2024-2034) & (K Doses)
Table 57. Global Decoagulant Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Decoagulant Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Decoagulant Sales Market Share in Value by Application (2024-2034)
Table 60. Global Decoagulant Price by Application (2024-2034) & (USD/Dose)
Table 61. North America Decoagulant Sales by Application (2018-2024) (K Doses)
Table 62. North America Decoagulant Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Decoagulant Sales by Application (2018-2024) (K Doses)
Table 64. Europe Decoagulant Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Decoagulant Sales by Application (2018-2024) (K Doses)
Table 66. Asia-Pacific Decoagulant Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Decoagulant Sales by Application (2018-2024) (K Doses)
Table 68. Latin America Decoagulant Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Decoagulant Sales by Application (2018-2024) (K Doses)
Table 70. Middle East and Africa Decoagulant Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Decoagulant Sales by Country (2018-2024) & (K Doses)
Table 72. North America Decoagulant Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Decoagulant Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Decoagulant Sales Market Share in Value by Country (2018-2024)
Table 75. North America Decoagulant Sales by Country (2024-2034) & (K Doses)
Table 76. North America Decoagulant Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Decoagulant Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Decoagulant Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Decoagulant Sales by Country (2018-2024) & (K Doses)
Table 80. Europe Decoagulant Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Decoagulant Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Decoagulant Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Decoagulant Sales by Country (2024-2034) & (K Doses)
Table 84. Europe Decoagulant Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Decoagulant Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Decoagulant Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Decoagulant Sales by Region (2018-2024) & (K Doses)
Table 88. Asia-Pacific Decoagulant Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Decoagulant Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Decoagulant Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Decoagulant Sales by Region (2024-2034) & (K Doses)
Table 92. Asia-Pacific Decoagulant Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Decoagulant Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Decoagulant Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Decoagulant Sales by Country (2018-2024) & (K Doses)
Table 96. Latin America Decoagulant Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Decoagulant Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Decoagulant Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Decoagulant Sales by Country (2024-2034) & (K Doses)
Table 100. Latin America Decoagulant Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Decoagulant Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Decoagulant Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Decoagulant Sales by Country (2018-2024) & (K Doses)
Table 104. Middle East and Africa Decoagulant Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Decoagulant Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Decoagulant Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Decoagulant Sales by Country (2024-2034) & (K Doses)
Table 108. Middle East and Africa Decoagulant Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Decoagulant Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Decoagulant Sales Market Share in Value by Country (2024-2034)
Table 111. Sanofi Company Information
Table 112. Sanofi Introduction and Business Overview
Table 113. Sanofi Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 114. Sanofi Decoagulant Product
Table 115. Sanofi Recent Development
Table 116. Bayer Company Information
Table 117. Bayer Introduction and Business Overview
Table 118. Bayer Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 119. Bayer Decoagulant Product
Table 120. Bayer Recent Development
Table 121. Boehringer Ingelheim Company Information
Table 122. Boehringer Ingelheim Introduction and Business Overview
Table 123. Boehringer Ingelheim Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 124. Boehringer Ingelheim Decoagulant Product
Table 125. Boehringer Ingelheim Recent Development
Table 126. Johnson & Johnson Company Information
Table 127. Johnson & Johnson Introduction and Business Overview
Table 128. Johnson & Johnson Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 129. Johnson & Johnson Decoagulant Product
Table 130. Johnson & Johnson Recent Development
Table 131. Genentech (Roche) Company Information
Table 132. Genentech (Roche) Introduction and Business Overview
Table 133. Genentech (Roche) Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 134. Genentech (Roche) Decoagulant Product
Table 135. Genentech (Roche) Recent Development
Table 136. AstraZeneca Company Information
Table 137. AstraZeneca Introduction and Business Overview
Table 138. AstraZeneca Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 139. AstraZeneca Decoagulant Product
Table 140. AstraZeneca Recent Development
Table 141. Bristol-Myers Squibb Company Information
Table 142. Bristol-Myers Squibb Introduction and Business Overview
Table 143. Bristol-Myers Squibb Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 144. Bristol-Myers Squibb Decoagulant Product
Table 145. Bristol-Myers Squibb Recent Development
Table 146. Aspen Company Information
Table 147. Aspen Introduction and Business Overview
Table 148. Aspen Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 149. Aspen Decoagulant Product
Table 150. Aspen Recent Development
Table 151. Lilly Company Information
Table 152. Lilly Introduction and Business Overview
Table 153. Lilly Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 154. Lilly Decoagulant Product
Table 155. Lilly Recent Development
Table 156. Otsuka Company Information
Table 157. Otsuka Introduction and Business Overview
Table 158. Otsuka Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 159. Otsuka Decoagulant Product
Table 160. Otsuka Recent Development
Table 161. Pfizer Company Information
Table 162. Pfizer Introduction and Business Overview
Table 163. Pfizer Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 164. Pfizer Decoagulant Product
Table 165. Pfizer Recent Development
Table 166. Daiichi Sankyo Company Information
Table 167. Daiichi Sankyo Introduction and Business Overview
Table 168. Daiichi Sankyo Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 169. Daiichi Sankyo Decoagulant Product
Table 170. Daiichi Sankyo Recent Development
Table 171. The Medicines Company Company Information
Table 172. The Medicines Company Introduction and Business Overview
Table 173. The Medicines Company Decoagulant Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 174. The Medicines Company Decoagulant Product
Table 175. The Medicines Company Recent Development
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Decoagulant Market Trends
Table 179. Decoagulant Market Drivers
Table 180. Decoagulant Market Challenges
Table 181. Decoagulant Market Restraints
Table 182. Decoagulant Distributors List
Table 183. Decoagulant Downstream Customers
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Decoagulant Product Picture
Figure 2. Global Decoagulant Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Decoagulant Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Decoagulant Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Platelet Aggregation Inhibitors (PAI)
Figure 6. Global Platelet Aggregation Inhibitors (PAI) Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Low-Molecular-Weight Heparin (LMWH)
Figure 8. Global Low-Molecular-Weight Heparin (LMWH) Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Product Picture of Direct Thrombin Inhibitor (DTI)
Figure 10. Global Direct Thrombin Inhibitor (DTI) Sales YoY Growth (2018-2034) & (K Doses)
Figure 11. Product Picture of Direct Factor Xa Inhibitors (DFXa)
Figure 12. Global Direct Factor Xa Inhibitors (DFXa) Sales YoY Growth (2018-2034) & (K Doses)
Figure 13. Product Picture of Vitamin K Antagonists (VKA)
Figure 14. Global Vitamin K Antagonists (VKA) Sales YoY Growth (2018-2034) & (K Doses)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Doses)
Figure 17. Global Decoagulant Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Decoagulant Sales Market Share by Type in 2022 & 2034
Figure 19. North America Decoagulant Sales Market Share in Volume by Type in 2022
Figure 20. North America Decoagulant Sales Market Share in Value by Type in 2022
Figure 21. Europe Decoagulant Sales Market Share in Volume by Type in 2022
Figure 22. Europe Decoagulant Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Decoagulant Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Decoagulant Sales Market Share in Value by Type in 2022
Figure 25. Latin America Decoagulant Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Decoagulant Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Decoagulant Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Decoagulant Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Decoagulant Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Decoagulant Revenue in 2022
Figure 31. Decoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of VTE
Figure 33. Global VTE Sales YoY Growth (2018-2034) & (K Doses)
Figure 34. Product Picture of ACS/MI
Figure 35. Global ACS/MI Sales YoY Growth (2018-2034) & (K Doses)
Figure 36. Product Picture of AF
Figure 37. Global AF Sales YoY Growth (2018-2034) & (K Doses)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Doses)
Figure 40. Global Decoagulant Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Decoagulant Sales Market Share by Application in 2022 & 2034
Figure 42. North America Decoagulant Sales Market Share in Volume by Application in 2022
Figure 43. North America Decoagulant Sales Market Share in Value by Application in 2022
Figure 44. Europe Decoagulant Sales Market Share in Volume by Application in 2022
Figure 45. Europe Decoagulant Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Decoagulant Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Decoagulant Sales Market Share in Value by Application in 2022
Figure 48. Latin America Decoagulant Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Decoagulant Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Decoagulant Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Decoagulant Manufacturing Cost Structure
Figure 53. Decoagulant Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries